短期和长期口服THA与卵磷脂治疗阿尔茨海默病：一项双盲研究。
Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
作者信息
Fitten L J, Perryman K M, Gross P L, Fine H, Cummins J, Marshall C
机构信息
VA Medical Center, Sepulveda, Calif 91343.
出版信息
Am J Psychiatry. 1990 Feb;147(2):239-42. doi: 10.1176/ajp.147.2.239.
PMID:2405720
Abstract
Ten Alzheimer's disease patients underwent a trial of oral tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there was no clear therapeutic effect. Three of six patients able to continue in long-term treatment showed measurable cognitive improvement, but only one displayed clinically obvious improvement.
摘要
十名阿尔茨海默病患者接受了口服他克林（THA）和卵磷脂的试验。经过三周的住院治疗，没有明显的治疗效果。在能够继续接受长期治疗的六名患者中，有三名显示出可测量的认知改善，但只有一名有临床上明显的改善。
Zotero 插件